About Autonomy Ventures
Autonomy Ventures is a venture capital firm founded in 2016. It is primarily based out of New York City, United States. As of May 2022, Autonomy Ventures has invested in 23 companies. It primarily invests in Seed round in Israel based startups. Its investments are spread across a wide range of sectors from High Tech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Seed round of Angular Finance Overall, Autonomy Ventures portfolio has seen 4 IPOs and 11 acquisitions including key companies like American Express, Ekso Bionics and Novocure. A lot of funds co-invest with Autonomy Ventures, with names like Figment Capital sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Autonomy Ventures' List of Top Investments
Autonomy Ventures has a portfolio of 23 companies. Their most notable investmentis in Angular FinanceTheir portfolio spans across United States, Israel and Canada. They have invested in High Tech, Enterprise Applications, Life Sciences and 16 other sectors, across stages such as Seed stage. Here is the list of top investments by Autonomy Ventures:Online comparison portal of financial products for individuals and businesses. The platform allows users to compare various financial products such as credit cards, corporate card, travel card, consumer loans, insurance and banking products.
Key facts about American Express
- Founded Year: 1850
- Location: New York City (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Employee Count: 10,000 - 1,000,000 as on Mar 01, 2026
- Investors: Black Capital Investments, B Capital Fund and 4 Others
- Latest Funding Round: Grant (prize money), May 13, 2019, $*****
- Highlight: Public
2. Ekso Bionics
Developer of exoskeletons for rehabilitation and personal mobility assistance. It offers devices intended for clinical use in rehabilitation settings. These devices are for individuals recovering from stroke, brain injury, spinal cord injury, and multiple sclerosis. Personal exoskeletons are available for home and community use. These are designed for individuals with spinal cord injuries.
Key facts about Ekso Bionics
- Founded Year: 2005
- Location: San Rafael (United States)
- Stage: Public
- Total Funding till date: $24.4M
- Employee Count: 61 as on Feb 28, 2025
- Investors: Western Technology Investment, Saints Capital and 14 Others
- Latest Funding Round: Post IPO, Dec 04, 2014, $*****
- Highlight: Public
3. Novocure
Developer of therapeutics to treat solid tumours. The company has developed a proprietary therapy for oncology patients suffering from solid organ cancers called Tumor Treating Fields, or TTFields. The company's therapy is used to treat Glioblastoma, Brain metastasis, Non-Small cell lung cancer, Ovarian cancer, Pancreatic cancer, and Mesothelioma.
Key facts about Novocure
- Founded Year: 2000
- Location: Haifa (Israel)
- Annual Revenue: $500M - $1B as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $10M
- Employee Count: 1,506 as on May 31, 2026
- Investors: Annox Capital, Autonomy Ventures and 13 Others
- Latest Funding Round: Post IPO, Nov 02, 2020, $*****
- Highlight: Public
4. Aurora Labs
AI-enabled remote software for connected vehicles. The system uses machine learning algorithms to analyze risks and changes in software functionality and behavior of in-vehicle software. It offers features like optimizes the cost, optimized the performance of the vehicles, etc.
Key facts about Aurora Labs
- Founded Year: 2016
- Location: Tel Aviv (Israel)
- Stage: Series C
- Total Funding till date: $97.1M
- Employee Count: 2 as on Jun 30, 2025
- Investors: Autonomy Ventures, Maniv Mobility and 30 Others
- Latest Funding Round: Series C, Jul 07, 2022, $*****
- Highlight: Editors' Pick
Provider of cryo-electron microscopy, protein production, and nanoparticle characterization services. They offer structural biology solutions, including sample preparation and computational infrastructure. The company’s services support structure-based drug design. They also offer method validation services.
Key facts about NanoImaging Services
- Founded Year: 2007
- Location: San Diego (United States)
- Stage: Series A
- Total Funding till date: $13.7M
- Employee Count: 39 as on May 31, 2026
- Investors: Autonomy Ventures, Ampersand Capital and 3 Others
- Latest Funding Round: Series A, Sep 04, 2024, $*****
- Highlight: Editors' Pick
Autonomy Ventures' Year-on-Year Investment Trends
Its most recent first time investment was in Angular Finance and most recent follow-on round was in Aurora Labs.Autonomy Ventures' Investments by Stage
Autonomy Ventures has made 1 investment in Seed stage with an average round size of $1.8M.Autonomy Ventures' Investments by Sector
Autonomy Ventures has a diverse portfolio, with companies operating in the Blockchain - Industry Applications, Blockchain Technology, FinTech and High Tech. Notably, it has invested in 19 Enterprise (B2B) companies, 19 Tech companies, 10 Software companies and at least 4 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Blockchain - Industry Applications | 1 |
Blockchain Technology | 1 |
FinTech | 1 |
High Tech | 1 |
Note: We have considered here, only first round of investments
Autonomy Ventures' Investments by Geography
Autonomy Ventures has made most investments in United States (1).Autonomy Ventures' recent investments
Autonomy Ventures has not made any investment in 2026 so far.Here are the most recent investments by Autonomy Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 24, 2022 | United States | Seed | 3484 | [+9] | |
- | Israel | Seed | 9015 | - |
IPOs and Publicly Listed companies in Autonomy Ventures' Portfolio
4 of Autonomy Ventures' portfolio companies have become public. Novocure got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Oct 2015 at marketcap of $165M and HTG Molecular Diagnostics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $94.3M.Here are Autonomy Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 02, 2015 | - | - | 6484 | |
May 08, 2015 | - | - | 4591 | |
Jun 05, 2014 | - | - | 4230 | |
Jul 10, 1972 | - | - | 3666 |
Acquired companies in Autonomy Ventures' Portfolio
11 companies from Autonomy Ventures' portfolio have been acquired. The most recent acquisition was Symphony Health in May 2026 by HealthVerity for $*****.Here are Autonomy Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 05, 2026 | - | - | 2536 | |
Aug 21, 2025 | - | - | 6015 | |
Dec 18, 2024 | - | - | 6911 | |
Dec 21, 2020 | - | - | 2947 | |
Sep 25, 2020 | - | - | 7124 |
Co-investors of Autonomy Ventures
Over the past 4 years, 10 investors have co-invested in Autonomy Ventures's portfolio companies. This includes funds and angels.
- Top Co-investors of Autonomy Ventures: 10 investors entered a company along with Autonomy Ventures. These include investors like Figment Capital (1 company).
Recent News related to Autonomy Ventures
•
Angular Finance, a cross-chain financial market, completed $1.8 million in financing, and 0xVentures and others participated in the investmentTheblockbeats•May 24, 2022•, Figment, Big Brain Holdings, 0xVentures and 8 others
